Cargando…

Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands

Detalles Bibliográficos
Autores principales:	Probert, Fay, Yeo, Tianrong, Zhou, Yifan, Sealey, Megan, Arora, Siddharth, Palace, Jacqueline, Claridge, Timothy D. W., Hillenbrand, Rainer, Oechtering, Johanna, Kuhle, Jens, Leppert, David, Anthony, Daniel C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793797/ https://www.ncbi.nlm.nih.gov/pubmed/36582251 http://dx.doi.org/10.3389/fimmu.2022.1095038

Ejemplares similares

Determination of CSF GFAP, CCN5, and vWF Levels Enhances the Diagnostic Accuracy of Clinically Defined MS From Non-MS Patients With CSF Oligoclonal Bands
por: Probert, Fay, et al.
Publicado: (2022)

Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis
por: Probert, Fay, et al.
Publicado: (2021)

Identification of ORM1, vWF, SPARC, and PPBP as immune-related proteins involved in immune thrombocytopenia by quantitative LC-MS/MS
por: Yin, Dong-mei, et al.
Publicado: (2023)

Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model
por: Yeo, Tianrong, et al.
Publicado: (2022)

Staphylococcus aureus vWF-binding protein triggers a strong interaction between clumping factor A and host vWF
por: Viljoen, Albertus, et al.
Publicado: (2021)

Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma
por: Braendstrup, P., et al.
Publicado: (2012)

Objective biomarkers for clinical relapse in multiple sclerosis: a metabolomics approach
por: Yeo, Tianrong, et al.
Publicado: (2021)

CSF and Blood Levels of GFAP in Alexander Disease
por: Jany, Paige L., et al.
Publicado: (2015)

Immunodetection of oligoclonal bands in serum and CSF of Multiple Sclerosis patients
Publicado: (2015)

Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients
por: Leone, Maurizio A., et al.
Publicado: (2013)

CSF oligoclonal IgG bands are not associated with ALS progression and prognosis
por: Klose, Veronika, et al.
Publicado: (2023)

Mass Cytometry of CSF Identifies an MS-Associated B-cell Population
por: Johansson, David, et al.
Publicado: (2021)

GATA3-induced vWF upregulation in the lung adenocarcinoma vasculature
por: Xu, Yinghua, et al.
Publicado: (2017)

Lower levels of vWF are associated with lower risk of cardiovascular disease
por: van Paridon, Pauline C. S., et al.
Publicado: (2022)

Adaptive Evolution of the Venom-Targeted vWF Protein in Opossums that Eat Pitvipers
por: Jansa, Sharon A., et al.
Publicado: (2011)

The Level of vWF Antigen and Coagulation Markers in Hospitalized Patients with Covid-19
por: Al Otair, Hadeel, et al.
Publicado: (2021)

Distribution and history of extensional stresses on vWF surrogate molecules in turbulent flow
por: Pham, Oanh L., et al.
Publicado: (2022)

Is CSF neurofilament light chain measurement relevant for MS?
por: Matsui, Makoto
Publicado: (2020)

A Meta-analysis of the Value of vWF in the Diagnosis of Liver Cirrhosis with Portal Hypertension
por: Ding, Xiang-Chun, et al.
Publicado: (2018)

CSF parameters associated with early MRI activity in patients with MS
por: Klein, Ana, et al.
Publicado: (2019)

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS
por: Fissolo, Nicolás, et al.
Publicado: (2021)

An immuno-enrichment free, validated quantification of tau protein in human CSF by LC-MS/MS
por: Self, Wade, et al.
Publicado: (2022)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
por: Jurynczyk, Maciej, et al.
Publicado: (2017)

Evaluation of CSF kappa free light chains for the diagnosis of multiple sclerosis (MS): a comparison with oligoclonal bands (OCB) detection via isoelectric focusing (IEF) coupled with immunoblotting
por: Abid, Muhammad Abbas, et al.
Publicado: (2023)

Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels
por: Antoni, Guillemette, et al.
Publicado: (2011)

Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis
por: Barnes, Theresa, et al.
Publicado: (2012)

Mechanical Compression Effects on the Secretion of vWF and IL-8 by Cultured Human Vein Endothelium
por: Weiss, Dar, et al.
Publicado: (2017)

CSF1R signaling is a regulator of pathogenesis in progressive MS
por: Hagan, Nellwyn, et al.
Publicado: (2020)

Kappa Index versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders
por: Ferraro, Diana, et al.
Publicado: (2020)

Advanced MRI features in relapsing multiple sclerosis patients with and without CSF oligoclonal IgG bands
por: Zhao, Lin, et al.
Publicado: (2020)

A Novel Hybridization LC-MS/MS Methodology for Quantification of siRNA in Plasma, CSF and Tissue Samples
por: Yuan, Long, et al.
Publicado: (2023)

A blood-based metabolomics test to distinguish relapsing–remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application
por: Yeo, Tianrong, et al.
Publicado: (2020)

Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling
por: Yeo, Tianrong, et al.
Publicado: (2019)

Effects of Shear Stress on Production of FVIII and vWF in a Cell-Based Therapeutic for Hemophilia A
por: Trevisan, Brady, et al.
Publicado: (2021)

Relationship between Serum FGF21 and vWF Expression and Carotid Atherosclerosis in Elderly Patients with Hypertension
por: Bian, Jing, et al.
Publicado: (2022)

Does CSF pleocytosis have a predictive value for disease course in MS?
por: Lotan, Itay, et al.
Publicado: (2019)

CSF chitinase 3-like-1 association with disability of primary progressive MS
por: Pérez-Miralles, Francisco, et al.
Publicado: (2020)

CSF neurofilament light chain testing as an aid to determine treatment strategies in MS
por: Reyes, Saúl, et al.
Publicado: (2020)

Altered CSF Albumin Quotient Links Peripheral Inflammation and Brain Damage in MS
por: Puthenparampil, Marco, et al.
Publicado: (2021)

Tumefactive demyelination with a transient appearance of oligoclonal bands in MS under fingolimod
por: Okada, Kazumasa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6q8blmaum7ihoj0vbsabtqd08m